Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,890 | 747 | 91.0% |
| Travel and Lodging | $877.52 | 2 | 8.1% |
| Education | $99.99 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,245 | 90 | $0 (2024) |
| Medtronic MiniMed, Inc. | $1,163 | 8 | $0 (2020) |
| Novo Nordisk Inc | $820.01 | 87 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $702.29 | 35 | $0 (2024) |
| Lilly USA, LLC | $566.83 | 72 | $0 (2024) |
| Astellas Pharma US Inc | $510.15 | 22 | $0 (2024) |
| Allergan, Inc. | $504.29 | 33 | $0 (2020) |
| Amgen Inc. | $483.07 | 32 | $0 (2024) |
| PFIZER INC. | $473.63 | 52 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $406.35 | 35 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,525 | 197 | ABBVIE INC. ($479.14) |
| 2023 | $1,664 | 142 | ABBVIE INC. ($396.86) |
| 2022 | $1,141 | 86 | ABBVIE INC. ($208.03) |
| 2021 | $783.11 | 53 | AbbVie Inc. ($160.52) |
| 2020 | $1,877 | 57 | Medtronic MiniMed, Inc. ($1,163) |
| 2019 | $1,139 | 79 | Mylan Specialty L.P. ($174.14) |
| 2018 | $712.55 | 58 | Allergan Inc. ($79.68) |
| 2017 | $1,027 | 78 | Allergan Inc. ($219.93) |
All Payment Transactions
750 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: PAIN | ||||||
| 12/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.70 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.95 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Immunology | ||||||
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.91 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/05/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $3.80 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.31 | General |
| Category: Diabetes | ||||||
| 11/27/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.91 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Biological | ||||||
| 11/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.13 | General |
| Category: PAIN | ||||||
| 11/22/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $9.43 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: VACCINES | ||||||
| 11/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $3.68 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.25 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Transcatheter Heart Valves | ||||||
| 11/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Inflammation | ||||||
| 11/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $2.23 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $3.22 | General |
| Category: Diabetes | ||||||
| 11/08/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $3.98 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/06/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 2,218 | 3,023 | $349,838 | $155,676 |
| 2022 | 37 | 2,569 | 3,450 | $377,218 | $167,134 |
| 2021 | 38 | 2,124 | 3,223 | $349,140 | $155,935 |
| 2020 | 40 | 2,689 | 4,395 | $444,491 | $185,751 |
All Medicare Procedures & Services
148 procedure records from CMS Medicare Utilization — Page 2 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 82728 | Ferritin (blood protein) level | Office | 2023 | 20 | 22 | $638.00 | $293.92 | 46.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 11 | 11 | $385.00 | $190.74 | 49.5% |
| 83550 | Iron binding capacity | Office | 2023 | 19 | 20 | $380.00 | $171.40 | 45.1% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 18 | 20 | $360.00 | $165.80 | 46.1% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 16 | 19 | $361.00 | $165.73 | 45.9% |
| 83540 | Iron level | Office | 2023 | 19 | 20 | $280.00 | $126.80 | 45.3% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 14 | 16 | $256.00 | $49.76 | 19.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 15 | 18 | $73.00 | $39.60 | 54.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 249 | 593 | $123,882 | $47,882 | 38.7% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 156 | 170 | $45,598 | $21,298 | 46.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 169 | 169 | $32,391 | $20,666 | 63.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 145 | 217 | $32,106 | $13,293 | 41.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 37 | 159 | $19,732 | $8,657 | 43.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 36 | 105 | $18,694 | $8,029 | 42.9% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 49 | 67 | $9,881 | $4,623 | 46.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 69 | 69 | $6,486 | $4,589 | 70.8% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2022 | 70 | 76 | $8,877 | $4,123 | 46.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 21 | 22 | $7,602 | $3,335 | 43.9% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 46 | 59 | $6,570 | $3,082 | 46.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 13 | 16 | $7,208 | $3,031 | 42.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 150 | 170 | $6,120 | $2,820 | 46.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 165 | 173 | $4,844 | $2,273 | 46.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 172 | 185 | $4,255 | $1,918 | 45.1% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 17 | 17 | $3,547 | $1,655 | 46.7% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 46 | 46 | $10,258 | $1,615 | 15.7% |
About Dr. Troy Lunceford, MD
Dr. Troy Lunceford, MD is a Internal Medicine healthcare provider based in Salem, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1194842286.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Troy Lunceford, MD has received a total of $10,868 in payments from pharmaceutical and medical device companies, with $2,525 received in 2024. These payments were reported across 750 transactions from 65 companies. The most common payment nature is "Food and Beverage" ($9,890).
As a Medicare-enrolled provider, Lunceford has provided services to 9,600 Medicare beneficiaries, totaling 14,091 services with total Medicare billing of $664,496. Data is available for 4 years (2020–2023), covering 148 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Salem, UT
- Active Since 03/23/2007
- Last Updated 11/27/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1194842286
Products in Payments
- Minimed 670G System (Device) $1,163
- VRAYLAR (Drug) $736.43
- UBRELVY (Drug) $528.24
- Ozempic (Drug) $476.50
- FARXIGA (Drug) $378.73
- MOUNJARO (Drug) $301.06
- JARDIANCE (Drug) $295.29
- XARELTO (Drug) $286.40
- Veozah (Drug) $274.14
- NURTEC ODT (Drug) $234.39
- LATUDA (Drug) $229.70
- QULIPTA (Drug) $225.38
- Yupelri (Drug) $209.38
- TRADJENTA (Drug) $180.19
- ZENPEP (Drug) $171.40
- Rybelsus (Drug) $162.87
- Kerendia (Drug) $153.40
- SOLIQUA 100/33 (Biological) $145.08
- AIRSUPRA (Drug) $144.39
- LEQVIO (Drug) $144.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Salem
Dr. Michael Katcher, Md, MD
Internal Medicine — Payments: $124,347
Jonh Pineda-Bonilla, Md, MD
Internal Medicine — Payments: $51,042
Dr. Garry Miller, D.o, D.O
Internal Medicine — Payments: $17,070
David Bennion, Md, MD
Internal Medicine — Payments: $13,939
Mr. Gautam Jha, Md, MD
Internal Medicine — Payments: $11,191
Dr. Marshall Bahr, Md, Mba, MD, MBA
Internal Medicine — Payments: $10,601